These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27512872)

  • 1. Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report.
    Song SH; Park BG; Lee J; Kim MS; Kim YS; Kim HS
    Medicine (Baltimore); 2016 Aug; 95(32):e4521. PubMed ID: 27512872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
    Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.
    Revollo JY; Cuffy MC; Abu Jawdeh BG; Paterno F; Girnita A; Brailey P; Alloway RR; Woodle ES
    Transplant Proc; 2015 Sep; 47(7):2254-7. PubMed ID: 26361693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children.
    Adamusiak AM; Stojanovic J; Shaw O; Vaughan R; Sebire NJ; Drage M; Kessaris N; Marks SD; Mamode N
    Pediatr Nephrol; 2017 Feb; 32(2):359-364. PubMed ID: 27585679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pronase independent flow cytometry crossmatching of rituximab treated patients.
    Alheim M; Wennberg L; Wikström AC
    Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation across a positive crossmatch: a single-center experience.
    Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A
    Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
    Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
    Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation.
    In JW; Nam M; Rho EY; Shin S; Hong YJ; Park KU; Song EY
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
    Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y
    Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.
    Cippà PE; Gaspert A; Etter C; Guenduez Z; Ferrari-Lacraz S; Rüsi B; Fehr T
    Hum Immunol; 2014 May; 75(5):462-5. PubMed ID: 24530822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single center observation of the role of pre-existing HLA-DP antibodies in humoral rejection following renal transplantation.
    Nikaein A; Lerman M; Rofaiel G; Allam SR
    Transpl Immunol; 2018 Dec; 51():58-61. PubMed ID: 30237092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization.
    Osickova K; Hruba P; Kabrtova K; Klema J; Maluskova J; Slavcev A; Slatinska J; Marada T; Böhmig GA; Viklicky O
    Front Med (Lausanne); 2021; 8():780636. PubMed ID: 34970564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
    Thukral S; Shinde N; Mukherjee K; Ray DS
    Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Active Antibody-Mediated Rejection With Donor-Specific Anti-HLA-DP Antibodies Following Living Donor Kidney Transplantation: A Case Report.
    Fukuoka K; Tokodai K; Miyagi S; Nakanishi W; Nishimura R; Fujio A; Watanabe H; Taniuchi S; Naitoh T; Ishida T; Unno M; Kamei T
    Transplant Proc; 2020; 52(6):1937-1939. PubMed ID: 32586663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study.
    Kim DG; Lee J; Park Y; Kim MS; Jeong HJ; Kim SI; Kim YS; Kim BS; Huh KH
    BMC Nephrol; 2019 Dec; 20(1):456. PubMed ID: 31818254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.